Lecanemab trial finds slight slowing of cognitive decline, but clinical benefits are uncertain
Elisabeth Mahase
Topics & Concepts
Cognitive declineCognitionPsychologyCognitive psychologyEconomicsMedicineDementiaNeuroscienceInternal medicineDiseaseCancer-related cognitive impairment studiesDementia and Cognitive Impairment ResearchTryptophan and brain disorders